Consistent with this, CPT1A levels were found to be increased in miR-142−/−BCR-ABL LSKs and human BC CD34+CD38− cells compared with their respective mouse (miR-142+/+BCR-ABL LSKs) and human (CD34+CD38−) CP controls (Fig. 5b). This evidence concerns the gene ABL1 and breast cancer.